JP2011529882A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011529882A5 JP2011529882A5 JP2011521126A JP2011521126A JP2011529882A5 JP 2011529882 A5 JP2011529882 A5 JP 2011529882A5 JP 2011521126 A JP2011521126 A JP 2011521126A JP 2011521126 A JP2011521126 A JP 2011521126A JP 2011529882 A5 JP2011529882 A5 JP 2011529882A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- isolated
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 33
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 108090000623 proteins and genes Proteins 0.000 claims 13
- 102000004169 proteins and genes Human genes 0.000 claims 13
- 230000000840 anti-viral effect Effects 0.000 claims 12
- 241000700605 Viruses Species 0.000 claims 11
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 10
- 239000012634 fragment Substances 0.000 claims 10
- 102000039446 nucleic acids Human genes 0.000 claims 10
- 108020004707 nucleic acids Proteins 0.000 claims 10
- 150000007523 nucleic acids Chemical class 0.000 claims 10
- 239000002773 nucleotide Substances 0.000 claims 9
- 125000003729 nucleotide group Chemical group 0.000 claims 9
- 239000012472 biological sample Substances 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 241000711549 Hepacivirus C Species 0.000 claims 4
- 230000002401 inhibitory effect Effects 0.000 claims 4
- 208000036142 Viral infection Diseases 0.000 claims 3
- 108020001507 fusion proteins Proteins 0.000 claims 3
- 102000037865 fusion proteins Human genes 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 230000009385 viral infection Effects 0.000 claims 3
- 101710132601 Capsid protein Proteins 0.000 claims 2
- 101710094648 Coat protein Proteins 0.000 claims 2
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 claims 2
- 101710125418 Major capsid protein Proteins 0.000 claims 2
- 101710141454 Nucleoprotein Proteins 0.000 claims 2
- 101710083689 Probable capsid protein Proteins 0.000 claims 2
- 229920001542 oligosaccharide Polymers 0.000 claims 2
- 230000000699 topical effect Effects 0.000 claims 2
- 108010088751 Albumins Proteins 0.000 claims 1
- 102000009027 Albumins Human genes 0.000 claims 1
- 241000702421 Dependoparvovirus Species 0.000 claims 1
- 241000713666 Lentivirus Species 0.000 claims 1
- 230000006229 amino acid addition Effects 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000010836 blood and blood product Substances 0.000 claims 1
- 229940125691 blood product Drugs 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000012636 effector Substances 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 239000003022 immunostimulating agent Substances 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- -1 mannose oligosaccharide Chemical class 0.000 claims 1
- 210000004400 mucous membrane Anatomy 0.000 claims 1
- 230000007935 neutral effect Effects 0.000 claims 1
- 150000002482 oligosaccharides Chemical class 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 210000000582 semen Anatomy 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 239000003053 toxin Substances 0.000 claims 1
- 231100000765 toxin Toxicity 0.000 claims 1
- 108700012359 toxins Proteins 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
- 241001430294 unidentified retrovirus Species 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13751108P | 2008-07-31 | 2008-07-31 | |
| US61/137,511 | 2008-07-31 | ||
| PCT/US2009/004420 WO2010014248A2 (en) | 2008-07-31 | 2009-07-31 | Antiviral activity of the protein scytovirin and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011529882A JP2011529882A (ja) | 2011-12-15 |
| JP2011529882A5 true JP2011529882A5 (enExample) | 2012-09-13 |
Family
ID=41610899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011521126A Pending JP2011529882A (ja) | 2008-07-31 | 2009-07-31 | タンパク質シトビリンの抗ウィルス活性及び使用方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20110183894A1 (enExample) |
| EP (1) | EP2320926A2 (enExample) |
| JP (1) | JP2011529882A (enExample) |
| WO (1) | WO2010014248A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006002106B4 (de) * | 2006-01-17 | 2016-03-03 | Robert Bosch Gmbh | Mikromechanischer Sensor mit perforationsoptimierter Membran sowie ein geeignetes Hestellungsverfahren |
| WO2019108656A1 (en) | 2017-11-28 | 2019-06-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Microbicidal composition |
| CN112345507B (zh) * | 2020-11-06 | 2022-07-05 | 济南大学 | 一种基于dna三棱柱结构构象变化靶向癌细胞的生物传感器 |
| KR20240169648A (ko) | 2022-03-24 | 2024-12-03 | 다니스코 유에스 인크. | 렉틴의 산업적 규모의 생산 및 회수를 위한 조성물 및 방법 |
| WO2024064653A1 (en) | 2022-09-20 | 2024-03-28 | Dupont Nutrition Biosciences Aps | Variant anti-viral polypeptides |
| WO2025007098A1 (en) | 2023-06-30 | 2025-01-02 | Danisco Us Inc. | Recombinant fungal cells and methods thereof for industrial scale production of lectins |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003097814A2 (en) * | 2002-05-16 | 2003-11-27 | The Government Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services | Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins |
| US8067530B2 (en) * | 2005-05-25 | 2011-11-29 | The United States Of America As Represented By The Department Of Health And Human Services | Scytovirin domain 1 related polypeptides |
-
2009
- 2009-07-31 JP JP2011521126A patent/JP2011529882A/ja active Pending
- 2009-07-31 US US13/056,892 patent/US20110183894A1/en not_active Abandoned
- 2009-07-31 EP EP09789047A patent/EP2320926A2/en not_active Withdrawn
- 2009-07-31 WO PCT/US2009/004420 patent/WO2010014248A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6294828B2 (ja) | インフルエンザウイルスワクチンおよびその使用 | |
| JP2011529882A5 (enExample) | ||
| CN113527510A (zh) | 融合蛋白分子及其制备方法和用途 | |
| ES2781085T3 (es) | Mutantes de griffithsina | |
| EA022932B1 (ru) | Димерные слитые белки vstm3 и связанные с ними композиции и способы | |
| WO2008135237A1 (en) | Complement factor h-derived short consensus repeat-antibody constructs | |
| JP2012504602A5 (enExample) | ||
| Odemuyiwa et al. | An outbreak of African swine fever in Nigeria: virus isolation and molecular characterization of the VP72 gene of a first isolate from West Africa | |
| JP2017529326A5 (enExample) | ||
| JP2011504169A5 (enExample) | ||
| WO2020154640A1 (en) | Compositions and methods for stimulating natural killer cells | |
| WO2004085633A8 (en) | A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof | |
| JP2012162567A (ja) | 変えられた空間構造を備えるインターフェロン及びその応用 | |
| KR20030024876A (ko) | 리바비린 함유 백신 및 이것의 사용 방법 | |
| EP2428221B1 (en) | Dengue vaccine, pharmaceutical composition comprising the same, nucleotide molecule and antibody composition | |
| CN102311500B (zh) | 一种抗病毒融合蛋白及其应用 | |
| JP2021509254A (ja) | Ｈ３ｎ２亜型インフルエンザウイルスのヘマグルチニンタンパク質の突然変異体及びその使用 | |
| EP3342866B1 (en) | Polypeptide carrier for presenting target polypeptide and uses thereof | |
| US20110183894A1 (en) | Antiviral activity of the protein scytovirin and methods of use | |
| BR9707142A (pt) | Polinucleotìdeo purificado, dna, vetor, célula hospedeira, linhagem celular de hibridoma, anticorpo monoclonal, processos para produzir exodus, para aumentar a resistência à infecção por vìrus de imonudeficiência humana (hiv), para tratamento de infecção por vìrus de imonodeficiência humana (hiv), para proteção de células progenitoras de medula óssea contra os efeitos citotóxicos e para tratamento de doenças mieloproliferativas, e, uso de produto de proteina de exodus. | |
| Valbuena et al. | Effect of blocking the CXCL9/10-CXCR3 chemokine system in the outcome of endothelial-target rickettsial infections | |
| JP2018052953A (ja) | インフルエンザウイルスワクチンおよびその使用 | |
| EP3313435A1 (en) | Novel vaccines in prevention and treatment of malaria | |
| Rashedi et al. | Vitamin D3 administration to patients with confirmed COVID-19 | |
| CN102827248B (zh) | 一种具有抗日本脑炎病毒感染的三肽及其应用 |